Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (Ticker: 2667 HK) is a Chinese company operating traditional Chinese medicine healthcare services, including TCM hospitals, offline medical institutions, an Internet hospital, standardized management services for business customers, and healthcare-related products. The company plans to list H shares on the Hong Kong Stock Exchange Main Board on July 7, 2026.

According to the published terms, Beijing Tong Ren Tang Healthcare Investment is offering 108.15 million primary shares at an expected price range of HKD 5.48 to HKD 6.21 per share, targeting an offer size of approximately HKD 672 million, or about US$86 million. A 15% greenshoe facility covers an additional 16.22 million shares.

The company is domiciled in China and conducts its business in China. It is a subsidiary of TRT Group and operates within the group’s healthcare segment, while other listed TRT Group companies are mainly focused on the production and sale of traditional Chinese medicine healthcare products. Its network includes 12 self-owned offline medical institutions, an Internet hospital, and 10 managed offline medical institutions.